Work

Abstract PS2-02-07: Impact of BRCA homozygous copy loss on clinical outcomes of patients (pts) with metastatic breast cancer (MBC) treated with PARP inhibitors (PARPi)

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-02-07

Authors: A. Rodríguez-Hernández, J. Quintanilla, R. Graf, A. Schrock, A. Gasco, B. Bychkovsky, R. Kitadai, S. Morganti, D. Abravanel, S. Tolaney, J. Garber, R. Jeselsohn, N. Lin, F. Lynce

Institutions: Dana-Farber Cancer Institute, Foundation Medicine (United States)

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129216027

Cites:

Cited by:

Related to: